Integrating Equity in Topic Selection for Orphan Medicinal Products: Policy Implications for Health Technology Assessment in Rare Diseases

Applied Health Economics and Health Policy · Published 2026-05-17 · DOI 10.1007/s40258-026-01048-0

Free full text

Authors (3)

Fatemeh Hosseini, Mohammadreza Mobinizadeh, William V. Padula

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Hosseini, F., Mobinizadeh, M., Padula, W. (2026). Integrating Equity in Topic Selection for Orphan Medicinal Products: Policy Implications for Health Technology Assessment in Rare Diseases. Applied Health Economics and Health Policy. https://doi.org/10.1007/s40258-026-01048-0

Related articles

• Costs and Budget Impact of a Health System Strengthening Intervention for Hypertension and Cardiovascular Disease Care in Ghana · Applied Health Economics and Health Policy · 2026 · Same journal
• Active Transport Health Model: Valuing the Health Benefits of Active Transport · Applied Health Economics and Health Policy · 2026 · Same journal
• Funding Health Promotion Activities to Reduce Avoidable Hospital Admissions in Frail Older Adults (HomeHealth): Further Challenges to the “Cost-Effective but Unaffordable” Paradox · Applied Health Economics and Health Policy · 2025 · Same journal
• Action Plan to Better Approximate Reality in Cost-Effectiveness Analyses · Applied Health Economics and Health Policy · 2026 · Same journal
• The Price of Speed: Estimating the Impact of List Prices on Time to Availability of New Medicines in 18 European Countries · Applied Health Economics and Health Policy · 2026 · Same journal
• Agreement in Qualitative and Quantitative Assessments of Disease Severity: Evidence from Pharmaceutical Reimbursement in Sweden · Applied Health Economics and Health Policy · 2026 · Same journal
• Which Factors are Holding up the Integration of the Environmental Impact of Health Technologies in Health Technology Assessment? Insights from a Multi-Stakeholder Interview Study · Applied Health Economics and Health Policy · 2025 · Same journal
• Burden of Disease in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Scoping Review · Applied Health Economics and Health Policy · 2025 · Same journal
• Funding Multi-indication Medicines: A Scoping Review of Health Technology Assessment and Reimbursement Frameworks · Applied Health Economics and Health Policy · 2025 · Same journal
• A Review of the Application of Generic Preference-Based Instruments with Older People Across Care Settings · Applied Health Economics and Health Policy · 2026 · Same journal